Monday, December 06, 2010
Arsenic-based life? Not so fast.
Posted by
Kamel
at
5:07 PM
10
comments
Labels: alternative biochemistry
Friday, December 03, 2010
Cancer Carnival #40
The holidays are upon us, and it's a short carnival this month, so we'll kick things off with a short post. Alexey Bersenev at Stem Cell Assays points us to a new review of aldehyde dehydrogenase in stem cells.
Aldehyde dehydrogenase (ALDH) is a potent and “popular” marker for both normal adult and cancer stem cells in rodents (mice) and human. I was happy to find very recent and comprehensive review about role of ALDH in human stem cells.ALDH1, it seems, is not just a convenient marker of normal and cancer stem cells, but may play an important role in stem cell physiology.
Speaking of stem cells, I have a post up at the Stem Cell Network blog describing a new method for interconversion between cell types without first producing an induced pluripotent stem (iPS).
Because these cells never enter a pluripotent state, they were shown to not give rise to teratomas, and the resulting engraftments lacked leukemia stem cell properties, this suggests a decreased cancer risk compared to other alternatives that retain tumour potential.At Respectful Insolence, Orac describes the tolls of second-hand smoke.
One aspect of the results of this study that were particularly disturbing is that deaths due to secondhand smoke were skewed toward poor and middle-income countries, where children tended to die of lower respiratory infections associated with secondhand smoke. In Europe's high-income countries, only 71 child deaths were recorded for this study, while 35,388 deaths were in adults. In contrast, in Africa, there were an estimated 43,375 deaths potentially attributable to secondhand smoking in children compared with 9,514 in adults.Orac also discusses flaws in the described study, but overall evidence points to the dangers of second-hand smoke inhalation. Meanwhile at HighlightHEALTH, with over 1 billion smokers in the world producing second-hand smoke, Walter Jessen points out that tobacco prevention funding is at a 10-year low.
According to the latest data from the Federal Trade Commission, tobacco companies spend $12.8 billion a year on marketing; that equates to $25 tobacco companies spend to market tobacco products for every $1 the states spend to fight tobacco use. Perhaps not surprisingly, a recent CDC study reports that the number of adult smokers dropped between 2000 and 2005, but the adult smoking rate has stalled at 20-21% since 2005.Given that tobacco is the number one cause of preventable death in the US, and the toll of second-hand smoke on non-users described above, this isn't great news.
Finally, ERV talks about a paper discussing Merkel Cell Polyomavirus and it's role in Merkel cell carcinoma.
This paper isnt perfect. I have a lot of issues with it too-- BUT! I think it is a fantastic step in the right direction of establishing the role of a virus in a cancer and establishing the biochemistry of that interaction. This not only helps with the logic (there are some logical issues I have with XMRV-->prostate cancer) so people believe you, but if you elucidate the biochemistry/genetics/physiology, taking the issue beyond "WE CAN FIND THE VIRUS IN 80% CANKERS!", you can figure out potential avenues of treatment.Read the post for the full story.
That's it for this month's Cancer Research Blog Carnival. For older editions, visit the Carnival Homepage. Don't forget, the CRBC has subscription options; you can follow by email or RSS feed. An aggregated feed of credible, rotating health and medicine blog carnivals is also available. For a broader collection of science-related blog carnivals, sign up for the Science, Medicine, Environment and Nature Blog Carnival Twitter Feed.
Posted by
Kamel
at
1:48 PM
2
comments
Labels: blog carnival, cancer research
Wednesday, December 01, 2010
Gay Prostates
As an aside, can we get any pics of great (creepy) Movember mustaches now that its all over?
Posted by
Rob
at
10:38 PM
1 comments
Monday, November 29, 2010
Call for Posts
Posted by
Kamel
at
6:27 PM
0
comments
Labels: cancer carnival
Wednesday, November 17, 2010
The Costs of Cancer Treatment
Provenge has shown some success against advanced prostate cancer. But it also costs about $93,000. Gleevec can cost $4,500 per month. Revlimid, another cutting-edge treatment for multiple myeloma, can cost $10,000 per month. It's hard to see how these prices might come down when the market consists of patients increasingly fragmented not only by type of cancer but even by types of mutation.Or course this isn't a call for 'silver bullet' treatments; cancer isn't just one disease. But the economics can be tricky. Simple supply and demand suggests that market fragmentation and personalized medicine will only drive prices up and split research dollars. It isn't quite so simple, though. Most personalized medicines will be built on common technologies which could even have the opposite effect - higher demand for core technology, modified on a case-by-case basis. Still, looking at the above costs of cancer treatment, I'm glad to live in a country with universal health care.
Posted by
Kamel
at
1:27 PM
0
comments
Labels: cancer, economics, universal healthcare
Friday, November 12, 2010
Oh, Lately it's so Quiet
Elsewhere, there's some interesting food blogging at Casaubon's Book asking "Is the local food movement elitist", as well as at Tomorrow's Table where the author discusses GE crops and sustainability.
Finally, Scicurious and PZ Myers both highlight some science porn: MRIs of women having orgasms.
Hopefully those links will tide people over while I work on some new Bayblab content. It may be quiet around here, but we haven't gone anywhere.
Posted by
Kamel
at
10:31 AM
0
comments
Labels: science blogging
Friday, November 05, 2010
Cancer Carnival #39
With that in mind, it's also time for the latest edition of the Cancer Research Blog Carnival. It's a short one this month - remember that the carnival depends on submissions from readers, so be sure to submit your posts for next month.
First off, last month's host Highlight HEALTH sends us news of a campaign to end breast cancer by 2020, the first initiative of which is to develop a breast cancer vaccine.
Key to this strategy and the challenge for researchers will be the identification of molecular mechanisms shared among the various breast cancer subtypes that cause the disease. A breast cancer vaccine may be closer than you think. A report in Nature Medicine earlier this year reported an experimental vaccine that prevented breast cancer in mouse models.The National Breast Cancer Coalition has done more than just set an arbitrary deadline - January 1, 2020 - but has outlined a plan to get there. Read more about the efforts at Highlight HEALTH.
Here at the Bayblab, I take a look a paper that explores what it means to be "cancer literate" and what kind of public education is needed for a cancer literate public.
[T]he authors assembled a panel of cancer experts (oncologists, GPs, nurses from oncology wards, social workers, public health experts) who refined the answer over a number of rounds. For their purposes, literacy was "the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions."While there are some obvious answers, there are also some surprises as to what is included and excluded from a definition of cancer literacy.
Elsewhere, Christie at Observations of a Nerd debunks the myth that sharks don't get cancer.
There are a lot of myths out there about the marine world, but by far the one that bothers me the most is the notion that sharks don't get cancer. This simply untrue statement has led to the slaughter of millions of sharks via the industry for shark cartilage pills, which are sold to desperate cancer patients under the false pretense that they can help reduce or cure their illness.Meanwhile, Orac also takes a look "alternative" cancer therapy as he describes "Yet another cancer cure testimonial that tells us nothing".
Finally, White Coat Underground has a post up about sulforaphane-rich vegetables (eg. broccoli), cancer prevention and how to properly evaluate risk.
The other day, I took issue with a press release published on another website. It was titled, Discovery may help scientists boost broccoli’s cancer-fighting power, which I found to by hyperbolic and deceptive. The actual study being reported regarded the ability of certain compounds found in cruciferous vegetables such as broccoli to be absorbed from the cecums of rats. I dismissed the entire piece as being unsupportive of its ambitious headline.Read the whole post for a more detailed look at some aspects of the broccoli-cancer connection, and important tips on how to critically read the medical literature.
That's it for this month's Cancer Research Blog Carnival. For older editions, visit the Carnival Homepage. Don't forget, the CRBC has subscription options; you can follow by email or RSS feed. An aggregated feed of credible, rotating health and medicine blog carnivals is also available. For a broader collection of science-related blog carnivals, sign up for the Science, Medicine, Environment and Nature Blog Carnival Twitter Feed.
Posted by
Kamel
at
2:12 PM
0
comments
Labels: blog carnival, cancer research
Wednesday, November 03, 2010
The Starving Student Cookbook
There are plenty of great recipes there, whether a grad student or not, so take a look and you might find some new supper (or breakfast, or lunch) ideas.
And yes, there is a Ramen category.
Posted by
Kamel
at
7:39 AM
1 comments
Labels: budget, food, graduate school
Tuesday, November 02, 2010
Update your CPR.
Posted by
Rob
at
10:35 PM
0
comments
Labels: CPR
Saturday, October 30, 2010
Update on Sperm Bank Product Liability Lawsuit
Under the laws being tested, it seemed all that needed to be shown was that injury (in this case, genetic disease) occurred as a result of using the product (in this case, sperm), not that negligence or lack of testing was a factor. At the time, I wondered whether genetic disease even qualified as "injury" since the alternative to injury is not being born at all. It turns out the courts had the same consideration.
A few months after the initial ruling by a judge that the case could go forward, the judge reversed his decision - a reversal that was upheld by a federal appeals court, on the basis that the situation basically amounts to a "wrongful life" case:
"Simply put, a cause of action brought on behalf of an infant seeking recovery for wrongful life demands a calculation of damages dependant upon a comparison between the Hobson's choice of life in an impaired state and nonexistence," Barry wrote. "This comparison the law is not equipped to make."In addition to "wrongful life" considerations, the decision also points out other ways that treating genetic disease as injury is problematic.
Barry, who was joined by Judges Theodore A. McKee and Morton I. Greenberg, quoted from Becker v. Schwartz, a 1978 decision of New York's highest court, that said: "Whether it is better never to have been born at all than to have been born with even gross deficiencies is a mystery more properly to be left to the philosophers and the theologians."
The difficulties that B.D. now faces and will face are surely tragic, but New York law, which controls here, states that she “like any other [child], does not have a protected right to be born free of genetic defects.” To find the contrary would invite litigation for any number of claimed injuries and, even more problematic, require courts to identify certain traits below some arbitrarily established marker of perfection as “injuries.”So kids, it looks like you can't sue your parents after all.
Posted by
Kamel
at
7:49 AM
4
comments
Labels: legal actions, personal genetics, sperm
The Cancer Carnival is Coming
Posted by
Kamel
at
7:47 AM
0
comments
Labels: cancer carnival
Thursday, October 21, 2010
The case for public science
"Today, the union that represents federal government scientists launches a campaign to put the spotlight on science for the public good.
“Federal government scientists work hard to protect Canadians, preserve their environment and ensure our country’s prosperity but they face dwindling resources and confusing policy decisions,” says Gary Corbett, president of the Institute.
The Professional Institute of the Public Service of Canada is a national union. Among its 59,000 federal and provincial members are 23,000 professionals who deliver, among other knowledge products, scientific research, testing and advice for sound policy-making.
The recent decision to end the mandatory long form census is the latest step in a worrying trend away from evidence-based policy making. Restrictive rules are curtailing media and public access to scientists, while cutbacks to research and monitoring limit Canada’s ability to deal with serious threats and potential opportunities.
A new online information and action centre launched today – PUBLICSCIENCE.ca – (http://publicscience.ca) features interviews with the professionals who do science for the public good, experts who understand the critical importance of this work, and Canadians whose lives have been touched by public science.
PUBLICSCIENCE.ca is part of a broader campaign to underline the importance of science for the public good and to mobilize scientists and the public to press politicians to make a clear commitment to policies that support public science.
“Our members are proud of the work that they do as independent and non-partisan scientists and we are going to work with them to tell their stories,” says Corbett. “Their work impacts on the daily lives of Canadians. It is science that is not and cannot be done by industry or by universities.”"
Posted by
Anonymous Coward
at
4:53 PM
0
comments
Labels: public science
Friday, October 15, 2010
Alternative medicine flowchart
Posted by
Anonymous Coward
at
4:30 PM
2
comments
Labels: alternative therapy
What Should You Know About Cancer?
There are some key areas that are focused on: Aspects of cancer risk, aspects of information/detection, treatments, and coping with cancer/support. Some exclusions make sense, such as how tumours develop or rules for financing screenings, which are secondary to the average person being able to make appropriate health choices. Others are a bit more confusing. For example, knowing about behaviour or environmental factors that contribute to cancer are included in the concept of cancer literacy, but not knowledge about hereditary factors. Likewise, knowing about screening tests and their benefits is included, but not knowledge about groups for whom screening is advised. Cancer symptoms and warning signs also doesn't make the list, nor did limitations of screening, diagnostic procedures, or treatments
What do you think? Keeping in mind the goal is that a cancer literate person be able to recognize the need to consult an expert, but not to become an expert themselves, what should a person know to be considered "cancer literate"?
Posted by
Kamel
at
11:53 AM
1 comments
Thursday, October 14, 2010
Deepak Chopra: The Video Game
You may be familiar with Chopra from the recent flap when he was invited to speak at the Royal Ontario Museum, his issues with evolution, or his ongoing nonsense at the Huffington Post and his distaste for skepticism
Most of my stinging darts come from skeptics. Over the years I've found that ill-tempered guardians of scientific truth can't abide speculative thinking. [...] No skeptic, to my knowledge, ever made a major scientific discovery or advanced the welfare of others.If you're not familiar with him, you'll soon have a chance to learn all about him on your Xbox or Playstation.
Game developer THQ, whose franchises include Saints Row and Red Faction, and licensing agreements with WWE and UFC, has bought the exclusive video game rights to Chopra's "teachings" for all the major gaming consoles.
It's unclear what the games might entail. I suppose dodging the darts of skeptics and scientists could be kinda fun.
Posted by
Kamel
at
10:32 PM
1 comments
Labels: video game
Wednesday, October 13, 2010
Water Droplet Bouncing on a Superhydrophobic Carbon Nanotube Array
Posted by
Anonymous Coward
at
1:24 PM
0
comments
Friday, October 08, 2010
Everybody's Working for the Weekend
In a recent editorial in Cancer Biology and Therapy, Dr. Kern takes a swipe at cancer researchers' lack of passion. Their "country-club mentality". Their desire for a life outside the lab.
During the survey period, off-site laypersons offer comments on my observations. “Don’t the people with families have a right to a career in cancer research also?” I choose not to answer. How would I? Do the patients have a duty to provide this “right”, perhaps by entering suspended animation? [...] Should I note that productive scientists with adorable family lives may have “earned” their positions rather than acquiring them as a “right”? Which of the other professions can adopt a country-club mentality, restricting their activities largely to a 35–40 hour week?Read the whole thing if you don't mind being irritated.
Or just skip that part and read one of the many great responses by the likes of Isis the Scientist, Mike the Mad Biologist (here also), Drugmonkey, Scicurious, and Janet Stemwedel (and here).
Or just skip it all, and just watch this video:
Posted by
Kamel
at
11:51 PM
4
comments
Labels: cancer research, lab culture, work habits
Friday, October 01, 2010
2010 IgNobels Announced!
PEACE PRIZE: Richard Stephens, John Atkins, and Andrew Kingston of Keele University, UK, for confirming the widely held belief that swearing relieves pain. (Bayblab link: F-ing Pain)
PUBLIC HEALTH PRIZE: Manuel Barbeito, Charles Mathews, and Larry Taylor of the Industrial Health and Safety Office, Fort Detrick, Maryland, USA, for determining by experiment that microbes cling to bearded scientists. (Bayblab link: A History of Beardism and the Science that Backs it)
BIOLOGY PRIZE: Libiao Zhang, Min Tan, Guangjian Zhu, Jianping Ye, Tiyu Hong, Shanyi Zhou, and Shuyi Zhang of China, and Gareth Jones of the University of Bristol, UK, for scientifically documenting fellatio in fruit bats. (Bayblab link: Fruit bat blowjobs)
Other highlights:
MEDICINE PRIZE: Simon Rietveld of the University of Amsterdam, The Netherlands, and Ilja van Beest of Tilburg University, The Netherlands, for discovering that symptoms of asthma can be treated with a roller-coaster ride.
PHYSICS PRIZE: Lianne Parkin, Sheila Williams, and Patricia Priest of the University of Otago, New Zealand, for demonstrating that, on icy footpaths in wintertime, people slip and fall less often if they wear socks on the outside of their shoes.
See the full list of this year's winners.
Posted by
Kamel
at
11:24 AM
1 comments
Labels: ignobel
Cancer Research Blog Carnival #38 - Breast Cancer Awareness Month
Welcome to the 38th edition of the Cancer Research Blog Carnival, the monthly blog carnival that discusses what’s new in cancer research. In recognition of October being Breast Cancer Awareness Month, this edition’s focus is on breast cancer.As usual, Walter has done a fantastic job hosting, with a carnival loaded quality posts. Go check it out.
Posted by
Kamel
at
1:55 AM
0
comments
Labels: blog carnival, cancer carnival, cancer research



Podcast




10 comments:
Post a Comment